Chemical Structure : Lipofermata
CAS No.: 297180-15-5
Catalog No.: PC-35366Not For Human Use, Lab Use Only.
Lipofermata (CB16.2 aka) is a specific fatty acid transport (FATP) inhibitor, blocks human FATP2-mediated fatty acid uptake (IC50=4.84 uM in Caco-2 cells) without impacting other cellular functions.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $158 | In stock | |
10 mg | $248 | In stock | |
25 mg | $398 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Lipofermata (CB16.2 aka) is a specific fatty acid transport (FATP) inhibitor, blocks human FATP2-mediated fatty acid uptake (IC50=4.84 uM in Caco-2 cells) without impacting other cellular functions.
Lipofermata demonstrates cellualr transport inhibition activity models for myocytes (mmC2C12), pancreatic β-cells (rnINS-1E), intestinal epithelial cells (hsCaco-2), and hepatocytes (hsHepG2), as well as primary human adipocytes, which is specific for long and very long chain fatty acids but has no effect on medium chain fatty acids (C6-C10).
Lipofermata also abrogates lipid transport into melanoma cells and reduces melanoma growth and invasion.
M.Wt | 360.229 | |
Formula | C15H10BrN3OS | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
5-bromo-5'-phenylspiro[1H-indole-3,2'-3H-1,3,4-thiadiazole]-2-one |
1. Ahowesso C, et al. Biochem Pharmacol. 2015 Nov 1;98(1):167-81.
2. Black PN, et al. Medchemcomm. 2016 Apr 1;7(4):612-622.
3. Zhang M, et al. Cancer Discov. 2018 Jun 14. pii: CD-17-1371.
4. Sandoval A, et al. Biochem Pharmacol. 2010 Apr 1;79(7):990-9.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright